Goldman Sachs’s Aurora Cannabis ACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-983
Closed -$255K 5181
2019
Q4
$255K Sell
983
-2,767
-74% -$1.03M ﹤0.01% 4809
2019
Q3
$1.98M Buy
+3,750
New +$2.78M ﹤0.01% 3539

Other funds holding ACB

Goldman Sachs's ACB Position: Q1 2026 in Review

Goldman Sachs increased its Aurora Cannabis (ACB) stake by 6.4% in Q1 2026, buying an estimated $238K and bringing the position to 1,056,218 shares worth $3.45M. The position accounts for ﹤0.01% of the portfolio, ranked #4048.

Goldman Sachs first reported a position in ACB in Q4 2018 and has held it in 29 quarters since. The position peaked at $10.3M in Q3 2025. 155 funds tracked by Wall St. Rank hold ACB as of Q1 2026.

  • Goldman Sachs held 1,056,218 shares of Aurora Cannabis worth $3.45M as of Q1 2026.
  • Goldman Sachs bought 63,087 Aurora Cannabis shares in Q1 2026, an estimated $238K.
  • Aurora Cannabis made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #4048 holding.
  • Goldman Sachs first reported a position in Aurora Cannabis in Q4 2018 and has held it in 29 quarters since.
  • Goldman Sachs's Aurora Cannabis position peaked at $10.3M in Q3 2025.
  • 155 funds tracked by Wall St. Rank held Aurora Cannabis as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.